Histologically Pure Stage I Seminoma With an Elevated β-hCG of 4497 IU/l

Urology

Volumn 70, Issue 5, 2007, Pages 1007.e13-1007.e15

  Bjurlin, Marc A ^a   August, Carey Z ^a   Weldon Linne, Michael ^a   Totonchi, Emil ^a  

^a ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER STAGING; CASE REPORT; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LIGATION; MALE; ORCHIECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCROTAL PAIN; SCROTAL SWELLING; SEMINOMA; STAINING; SYNCYTIOTROPHOBLAST; TESTICULAR ENLARGEMENT;

EID: 36549017193     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.08.010     Document Type: Article

References (11)

1. Weissbach L., and Bussar-Maatz R. HCG-positive seminoma. Eur Urol 23 (1993) 29-32
2. Hartmann M., Pottek T., Bussar-Maatz R., et al. Elevated human chorionic gonadotropin concentrations in the testicular vein and in peripheral venous blood in seminoma patients: an analysis of various parameters. Eur Urol 31 (1997) 408-413
3. Mumperow E., and Hartmann M. Spermatic cord beta-human chorionic gonadotropin levels in seminoma and their clinical implications. J Urol 147 (1992) 1041-1043
4. Butcher D.N., Gregory W.M., Gunter P.A., et al. The biological and clinical significance of HCG-containing cells in seminoma. Br J Cancer 51 (1985) 473-478
5. Weissbach L., Bussar-Maatz R., Lohrs U., et al. Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group. Eur Urol 36 (1999) 601-608
6. Mirimanoff R.O., Sinzig M., Kruger M., et al. Prognosis of human chorionic gonadotropin-producing seminoma treated by postoperative radiotherapy. Int J Radiat Oncol Biol Phys 27 (1993) 17-23
7. Bruns F., Raub M., Schaefer U., et al. No predictive value of beta-hCG in patients with stage I seminoma-results of a long-term follow-up study after adjuvant radiotherapy. Anticancer Res 25 (2005) 1543-1546
8. Bosl G.J., Geller N.L., Cirrincione C., et al. Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 43 (1983) 3404-3407
9. Bosl G.J. Prognostic factors for metastatic testicular germ cell tumours: the Memorial Sloan-Kettering cancer model. Eur Urol 23 (1993) 182-187
10. Mazumdar M., Bajorin D.F., Bacik J., et al. Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy. J Clin Oncol 19 (2001) 2534-2541
11. Oliver R.T., Mason M.D., Mead G.M., et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366 (2005) 293-300